![David Meeker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Meeker
Chief Executive Officer at
RHYTHM PHARMACEUTICALS, INC.
Net worth: 28 M $ as of 2026-05-30
Profile
David P.
Meeker is Chairman, President & Chief Executive Officer at Rhythm Pharmaceuticals, Inc. since 2020, Chairman at Trevi Therapeutics, Inc. since 2017, Non-Executive Chairman at Pharvaris NV since 2021, Chairman at Pharvaris GmbH since 2021, Director at Biotechnology Innovation Organization, Director at New England Healthcare Institute, Director at Prize4Life, Inc., Independent Director at Turmeric Acquisition Corp., and Independent Non-Executive Director at Kardigan, Inc. since 2024.
Former roles include President, Chief Executive Officer & Director at Genzyme Corp.
from 2011 to 2017, President & Chief Executive Officer at Genzyme SAS from 2011 to 2017, President, Chief Executive Officer & Director at KSQ Therapeutics, Inc. from 2017 to 2020, Independent Director at Savient Pharmaceuticals, Inc. from 2013 to 2014, Director at Penwest Pharmaceuticals Co. from 2007 to 2010, Independent Director at MyoKardia, Inc. from 2017 to 2020, Director-Pulmonary Critical Care Fellowship at The Cleveland Clinic Foundation, Assistant Professor at The Ohio State University, Executive Vice President at Sanofi from 2012 to 2017, and Senior Vice President at Sanofi BV in 2003.
Education includes a doctorate from the University of Vermont College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 239,016 ( 0.35% ) | 21 M $ | 2026-05-30 | |
| 2026-06-02 | 352,489 ( 0.29% ) | 5 M $ | 2026-05-30 | |
PHARVARIS N.V. 0.09% | 2026-03-17 | 65,167 ( 0.09% ) | 2 M $ | 2026-05-30 |
David Meeker active positions
| Companies | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Executive Officer | 2020-07-19 |
| TREVI THERAPEUTICS, INC. | Chairman | 2017-06-30 |
| TURMERIC ACQUISITION CORP. | Director/Board Member | - |
| PHARVARIS N.V. | Chairman | - |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chairman | 2021-01-04 |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Director/Board Member | - |
Prize4Life, Inc.
 Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicated to accelerating the discovery of treatments and cures | Director/Board Member | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of David Meeker
| Companies | Position | End |
|---|---|---|
| MYOKARDIA, INC. | Director/Board Member | 2020-11-30 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of David Meeker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical & biotherapeutic products | Health Technology |
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Genzyme SAS
 Genzyme SAS BiotechnologyHealth Technology Develops biotechnology solutions | Health Technology |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicated to accelerating the discovery of treatments and cures | Commercial Services |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
University of Vermont College of Medicine
 University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- David Meeker
